Should you trust a blood test to detect cancer?

Elie Dolgin • November 18, 2026

Multi-cancer blood tests have yet to beat standard screenings.

Melissa Wells was feeling perfectly healthy when an experimental blood test, called Galleri, pointed doctors to a cancer hiding in her bile ducts. Scans and a biopsy confirmed a small, localized tumor — the kind that often grows silently for years before spreading beyond the reach of treatment.


Yet, because it was caught early, surgeons could cut the tumor out. Wells, now one year cancer-free, credits the blood test with giving her a chance at a long life.


“If I hadn’t taken this,” said Wells, 54, “who knows what would have happened?”


In September, Wells and three other patients appeared before a panel of FDA advisers who were considering whether Galleri should be approved by the agency. Each patient had an undiagnosed cancer in a different organ — bile ducts, esophagus, gallbladder and pancreas — that were identified by the Galleri blood test. All the cancers were found before they caused symptoms and all were treatable.


“I want to tell you: there are real people here,” Roger Royse, whose early stage pancreatic cancer was detected by Galleri, told the advisory group. “We’re not just statistics.”


Continue reading at Aventine.

By Elie Dolgin • November 18, 2026
Researchers have some of the first rigorous evidence that pumping iron is worth the effort, though perhaps not for the reason most people expect.
By Elie Dolgin • November 17, 2026
The largest test of 40-Hz therapy delivers a split verdict.